Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and azoxymethane

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with azoxymethane in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(azoxymethane)		Trials
(azoxymethane)		Recent Studies (post-2010) (azoxymethane)
9,1561875521,7661745

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, X; He, Z; Hu, J; Ke, J; Lan, P; Li, S; Lian, L; Sun, L; Wu, X; Zou, Y1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and azoxymethane

ArticleYear
PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:1

    Topics: Animals; Azoxymethane; Carcinogenesis; Colitis; Dextran Sulfate; Female; Ginkgolides; Lactones; Mice; Neovascularization, Pathologic; Plant Extracts; Platelet Activating Factor

2015